Assistive devices: usage in patients with rheumatoid arthritis by I. G. de Boer et al.
ORIGINAL ARTICLE
Assistive devices: usage in patients with rheumatoid arthritis
I. G. de Boer & A. J. Peeters & H. K. Ronday &
B. J. A. Mertens & T. W. J. Huizinga &
T. P. M. Vliet Vlieland
Received: 21 April 2008 /Revised: 3 July 2008 /Accepted: 23 July 2008 / Published online: 26 August 2008
# The Author(s) 2008. This article is published with open access at Springerlink.com
Abstract We describe the usage of various assistive devices
and identify factors associated with usage in patients with
rheumatoid arthritis (RA). A cross-sectional, multicentre
study was performed in three outpatient rheumatology clinics
in the Netherlands. Two hundred forty patients with RA
participated in the study. The main measures were question-
naires and a semi-structured interview regarding the posses-
sion and usage of 21 common assistive devices in the
ISO9999 categories orthopaedic footwear, personal care,
mobility, household and adaptations for housing. Potential
factors associated with usage included sociodemographic
variables, health status, quality of life, coping strategies, self-
efficacy, outcome expectations and satisfaction. Out of 240
patients, 213 (89%) had one or more assistive devices in
possession (median number of devices 3.0, interquartile range
3.0). The proportions of patients never using a device in
possession varied between 8% for orthopaedic insoles and
23% for grab bars. The main factors related to usage varied
among categories, but common determinants were a specific
impairment or disability, satisfaction with the device or related
services, self-efficacy and the number of devices in posses-
sion. In conclusion, in patients with RA, possession rates are
high, with 23% or less of the devices in possession being
abandoned. Overall, satisfaction rates were high. Factors
associated with usage varied among categories and com-
prised, apart from the number of devices in possession and
variables related to health status, also aspects of satisfaction
with the device or related services or self-efficacy. The latter
findings underline the need for a systematic evaluation of the
outcomes of assistive devices by prescribing health profes-
sionals or suppliers in every individual case.
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Introduction
Assistive devices are frequently prescribed in patients with
rheumatoid arthritis (RA), with the aim of improving or
maintaining the patient’s functional ability and indepen-
dence.[1, 2] A pre-requisite for assistive devices to be
effective is, apart from their possession, their actual usage.
Until now, both the possession of assistive devices and the
adherence with their use are poorly studied.
Concerning possession, the proportions of RA patients
having one or more assistive devices varies between 34% and
78% in the literature [3–7]. Variable possession rates may be
due to differences in patient selection, the number and nature
of the assistive devices being studied and the country or
health care system where the study was conducted.
In studies focusing on the usage of assistive devices, the
overall usage rate for assistive devices varied between 40%
and 91% [2, 3, 7–10]. It was found that the usage of
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assistive devices was associated with higher age [2, 7, 11],
more severe disease [2, 3, 7, 12], more disability [2, 3, 7, 12]
and a beneficial effect or positive evaluation of the device.[2,
7, 9, 12] In these studies, a number of factors which are
likely to be relevant for the actual usage of adaptive devices,
such as the process of prescription and provision and the
patient’s evaluation of the design and comfort of adaptive
devices, has not been taken into account.
The aim of the present study was to describe the usage of
assistive devices and to identify factors contributing to
usage in an unselected population of patients with RA.
More insight into the actual usage of various assistive
devices in daily practice, as well as factors related to their
usage and non-usage could help rheumatologists and health
professionals to define clear indications for their prescrip-
tion or the provision of alternative solutions to relieve
symptoms or reduce disability.
Patients and methods
Patients
This study was a multicentre, cross-sectional study per-
formed between 2002 and 2004 in the rheumatology
outpatient clinics of three hospitals (Leiden University
Medical Center, LUMC; Haga-Leyenburg Teaching Hospi-
tal, The Hague; and Reinier de Graaf Hospital, Delft). In
the Netherlands, the prescription process of assistive
devices in patients with RA usually concerns the rheuma-
tologist, the clinical nurse specialist, the occupational
therapist or, less frequently, the physical therapist. In all
three centres, patients had access to a clinical nurse
specialist. In addition, patients could be referred to an
occupational therapist or physical therapist in primary care
or in a rehabilitation centre or to a multidisciplinary team
care programme of the Rheumatology Clinic of the LUMC
if considered necessary by their treating rheumatologist.
Inclusion criteria were (1) a diagnosis of RA according to
the 1987American College of Rheumatology criteria [13] and
(2) being fluent in Dutch. There were no exclusion criteria.
In the three hospitals, registries of patients with a clinical
diagnosis of RAwere sorted in ascending order by the day of
the month of the patients’ birthdays or by the date of their
forthcoming visit to the outpatient clinic. The registries
comprised 765, 1,122 and 360 patients in the three hospitals,
respectively. Recruitment was done until the target number
of 250 was reached. First, the diagnosis of RA was verified
in the medical records by the principal investigator (IGB).
Second, eligible patients were contacted by telephone to
check whether they were able to communicate in Dutch
and subsequently invited to participate in the study. Of
the eligible patients who could not be reached by phone
or declined participation, age, gender and disease duration
were recorded. All participants were required to sign the
informed consent. The protocol received ethical approval
from the Medical Ethics Committees of all three participat-
ing hospitals.
Measurements
Data on the presence of an impairment or activity limitation
related to the specific assistive device and the possession
and usage of that device were gathered by means of a semi-
structured interview, which was carried out in the outpatient
clinics of the participating hospitals. During this visit, a 28-
joint count [14] was performed. Both the semi-structured
interview and the joint count were done by a trained
assessor, the principal investigator of the study (IGB).
In addition, participants filled in a questionnaire,
comprising sociodemographic characteristics, disease char-
acteristics and questionnaires on physical and mental
functioning, coping and satisfaction with assistive devices
in possession.
Moreover, data regarding the medical history (disease
duration, presence of erosions, current use of disease-
modifying anti-rheumatic drugs (DMARDS) and oral
corticosteroids) and a recent (<3 months) erythrocyte
sedimentation rate (ESR) were abstracted from the medical
record by the principal investigator.
Semi-structured interview
To determine the presence of impairments or activity
limitations related to specific assistive devices, the possession
and usage and the reasons for usage or non-usage, a semi-
structured, in-depth interview including a photo presentation
of 21 assistive devices that are frequently prescribed in the
Netherlands was used. The interview method was used to
avoid misunderstandings regarding the possession of specific
devices. We hypothesised that by just mentioning the name of
a device some patients might not recognise it. In addition, at
the time the study was conceived and the protocol developed,
no validated self-administered questionnaires or standardised
theoretical frameworks for the assessment of individual
reasons for usage or non-usage of specific assistive devices
were available. As it was thought likely that there would be a
variety of experiences, knowledge and opinions of patients
playing a role, we decided to use open-ended questions for
this specific topic.
According to the ISO9999 classification, the assistive
devices were categorised into: orthopaedic footwear (or-
thopaedic shoes and insoles), personal care (wash and dry
bidet, shower chair, sock aid, bathtub seat–elevator),
mobility (work chair, rolling walker, mobility scooter,
electric wheelchair, bicycle with electric support), house-
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hold (loop scissors, reacher, good–angled grip cutlery,
electric can opener) and adaptations for housing (lift chair,
stairway chair lift, grab bars, electric bedspring, orthopaedic
pillow). Apart from the electric can opener, we did not
include consumer products because these may also be
commonly used by healthy people. In addition, for the sake
of relevance, we did not consider assistive devices costing
€20 or less at the time the study was conducted. With
relatively cheap assistive technology, potential savings in
case of any improvement in the process of advice,
prescription, instruction and delivery as a result of our
study would be marginal.
First, with every selected device, patients were asked
about the presence of an impairment or activity limitation
related to that assistive device in the past 3 months. These
problems were scored on a four-point scale ranging from 1
‘never’ up to 4 ‘always’.
Patients were then asked whether they had that specific
assistive device in possession. For that purpose, a photo
presentation of the device was used as an example. For
those who did possess that specific assistive device, the
following additional information was gathered:
– Frequency of usage in the past 3 months (eight pre-
defined categories: always, several times a day, once a
day, several times a week, once a week, once a month,
less than once a month, never)
– Individual main reasons for usage (open-ended ques-
tions; categories defined afterwards by IGB and TVV:
enabling or facilitating specific activity; reduction of
pain, fatigue, swelling or compensation for reduced
strength; joint protection; recommendation by physi-
cian, rheumatologist or health professional)
– Individual main reasons for non-usage (open-ended
questions; categories defined afterwards by IGB and
TVV: no impairment and/or activity limitation related
to device; negative evaluation of device, e.g. did not
met expectations, not easy to use, dislike the appear-
ance, lack of fit or comfort; other (having impairment
and/or activity limitation but not having reached that
stage yet; others peoples’ negative opinion; or other
impairment or activity limitation not related to device).
Patients could provide more than one activity or reason.
Any discrepancies with respect to the categorisation of
reasons for usage or non-usage by IGB and TVV were
solved by consensus.
Questionnaire and clinical assessment
Sociodemographics
Sociodemographic variables included age (years), gender,
educational level (categorised as low: up to and including
lower technical and vocational training; medium: up to and
including secondary technical and vocational training; high:
up to and including higher technical and vocational training
and university) and status of living (living alone or with
partner or children).
Disease characteristics
Disease duration (years) and current use of DMARDS and
oral corticosteroids were registered. Comorbidity was
assessed using a part of the Dutch Arthritis Impact
Measurement Scale II [15], and categorised into two
groups: no comorbid conditions and one or more comorbid
conditions.
General disease activity was assessed by means of the
Modified Disease Activity Score (DAS28 [16]), using the
ESR, the 28-joint count and the patients’ global assessment
of disease activity, measured on a horizontal visual
analogue scale (VAS, range 0–100 mm).
The DAS28 was calculated by the following formula:
0.56√(tender joints)+0.28√(swollen joints)+0.70 ln(ESR)+
0.014 (VAS patients’ global assessment of disease activity).
Measures of general pain and fatigue included a
horizontal VAS, range 0–100 mm. The left anchors were
no pain and no fatigue and the right anchors unbearable
pain and severe fatigue, respectively.
Physical and mental functioning
A validated Dutch version of the RAND 36-item Health
Survey (RAND-36 [17]) was used. The RAND-36 contains
eight subscales for: physical functioning, social function-
ing, role limitations (physical problem), role limitations
(emotional problem), mental health, vitality, pain and
general health perception. Each scale generates a score
from 0 to 100, with higher scores indicating better health.
The RAND-36 was converted to two summary scales: the
physical and mental component summary scales.
Coping
Coping strategies were assessed by the “coping with
rheumatic stressors” questionnaire [18], an arthritis-specific
coping questionnaire which measures eight coping strate-
gies directed at the most important chronic stressors of
inflammatory rheumatic disease: pain, limitations and
dependency. Our study included the measurement of five
coping styles related to pain (decreasing activities: eight
items), limitations (pacing: ten items, creative solution
seeking: eight items) and dependence (accepting: six items,
taking others into account: seven items). For each item,
patients reported how often they made use of that particular
coping strategy (1=seldom or never, 2=sometimes, 3=
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often, 4=very often). The scores were summed up per
coping strategy to give a coping strategy score. Higher
scores indicate more frequent use of that specific coping
strategy.
Satisfaction
All patients who possessed a device were asked to score
their satisfaction with different aspects of that specific
device by filling in the D-Quest (Dutch version of the
Quebec User Evaluation of Satisfaction with assistive
Technology [19]). This questionnaire comprises eight
aspects relating to the assistive device (ease of use,
effectiveness, comfort, adjustments, weight, durability,
dimensions, safety), four aspects relating to the process
of providing the assistive devices (service delivery, re-
pairs and servicing, professional services, follow-up ser-
vices), a general score for satisfaction with the device
and a general score for satisfaction with the process of
prescription and delivery. Each dimension is scored on
five-point scale ranging from 1 ‘not satisfied at all’ to 5
‘very satisfied’.
All answers were categorised afterwards in ‘satisfied’
(4=satisfied and 5=very satisfied) ‘not satisfied’ (1=not
satisfied at all, 2=not satisfied and 3=not satisfied–satisfied).
Statistical analysis
All analyses were conducted using SPSS 12.0 for Windows
(SPSS Chicago IL, USA). Frequency distributions and
summary statistics for the full sample as well as for the
three hospitals separately were obtained. For categorical
data, proportions were calculated; all other data were
expressed as median and interquartile ranges (IQR). To
analyse differences between the participants of the three
hospitals and between participants and non-participants
(eligible patients who were excluded, not reached by phone
or declined participation) the Mann–Whitney test for
continuous variables and the chi square for discrete
variables were conducted.
For each of the assistive devices, the usage rates were
categorised into three groups: 1 (always, several times a
day or once a day); 2 (several times a week or once a
week); and 3 (once a month, less then once a month or
never). In addition, the median usage rate was computed.
Moreover, within each ISO9999 category, the median
frequency of usage of all devices in possession in that
category was computed.
To determine which variables were associated with
usage, firstly univariate logistic regression analysis was
performed, with the results expressed as odds ratios with
the 95% confidence interval. The dependent variable was
the frequency of usage of assistive devices in a specific
category, dichotomised into >median frequency (=frequent
use) versus ≤median frequency (=non-frequent use). Only
variables that were statistically significantly associated with
usage in the univariate analyses (p value≤0.05) were then
entered into multivariate logistic regression models with the
same dependent variable. To exclude possible confounding,
the variables centre, age and gender were entered in the first
block, regardless of the statistical significance of the
univariate analyses (method forced entry), and in addition
the independent variables that reached statistical signifi-
cance in the univariate analysis were entered in the second
block (method stepwise forward).
Results
Of the 444 patients who were eligible according to the
diagnosis of RA in the database and the medical record,
362 (82%) could be reached by phone, whereas 82
patients (18%) could not be contacted by phone after a
maximum of three attempts. Out of 362 patients, 251 (69%)
agreed to participate in the study. Eleven patients were
excluded from the analysis at a later stage due to the absence
of all questionnaires or the interview, yielding a total
number of 240 participants (54%) and 204 non-participants
(46%).
The proportions of participants were similar in the three
centres (Leiden 138/242, 57%; Delft 63/124, 51%; and The
Hague 39/78, 50%, p=0.386). Concerning the character-
istics of participants and non-participants, the proportion of
female patients was significantly higher among participants
than among non-participants (185/240, 77% and 125/204,
61%, respectively; p<0.001). This difference was seen in
all three centres (data not shown).
Patient characteristics
The sociodemographic and disease characteristics and
coping strategies of the 240 participants are presented in
Table 1.
Possession and usage of assistive devices
Of the 240 subjects enrolled in the study, 213 (89%) had
at least one assistive device in possession (median number
of devices 3.0, IQR 3.0). Table 2 shows the frequencies of
possession for all 21 devices and for the categories of
devices. The assistive devices that were most frequently in
possession were: grab bars (44%), orthopaedic shoes
(38%), orthopaedic pillow (32%), shower chair (29%) and
electric can opener (27%). There were no significant dif-
ferences between the three hospitals regarding the frequen-
cies of possession (data not shown).
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With respect to usage, the median frequency of usage
varied between ‘always’ (=1.0) for orthopaedic shoes and
‘less than once a month’ (=7.0) for bathtub seat–elevator.
For devices in possession by 50 patients or more, the pro-
portions of patients who indicated that they never used the
device were: 11/132 (12%) for orthopaedic shoes, 4/53 (8%)
for orthopaedic insoles, 13/69 (19%) for a shower chair, 13/65
(20%) for an electric can opener, 24/105 (23%) for grab bars,
11/56 (20%) and 12/76 (16%) for an orthopaedic pillow.
Reported reasons for usage and non-usage
In Table 3, the main reasons for using or not using an
assistive device reported by the patients are presented. In all
five categories of assistive devices, the main reasons for
usage were ‘enabling or facilitating specific activities’ or
‘reduction of pain, fatigue, swelling or compensation for
reduced strength’, both among frequent users and non-
frequent users.
In addition, adaptations for housing and devices for
household and personal care were also used for safety
reasons.
The main reason for not using orthopaedic footwear was
a negative evaluation (ease of use, dislike the appearance,
did not fit well, comfort). The main reasons for not using an
assistive device in the other categories were ‘no impairment
or activity limitation related to the device’. All these
reasons for usage and non-usage mentioned in the inter-
views were covered by the previously mentioned potential
variables associated with usage and were therefore not
entered separately into the regression analyses.
Satisfaction
In Table 4, the proportions of patients being ‘satisfied–very
satisfied’ are shown for those devices that were in
possession by 50 patients or more. Overall, satisfaction
with the devices and with the providing process were high,
with, according to the general scores, 75% or more of the
patients being satisfied or very satisfied with the different
aspects of the device and the providing process. Regarding
specific aspects of satisfaction, satisfaction rates were the
lowest for orthopaedic shoes, specifically with the aspects
dimensions (50; 67%), weight (51; 68%) and comfort (54;
71%). Patients were also less satisfied with the aspect
adjustments of the electric can opener (24; 60%), implying
that it was not suitable for different kinds of cans.
Factors associated with the usage of assistive devices
The findings of the multivariate logistic analyses for usage
of assistive devices are presented in Table 5. The data
indicate that pain and the presence of an impairment or
limitation related to a specific device were positively
associated with frequent usage within the categories
orthopaedic footwear, personal care and adaptations for
housing.
Self-efficacy was positively associated with usage in the
categories mobility and household, general satisfaction with
the usage in the categories orthopaedic footwear and
personal care and satisfaction with the prescription and
provision process with usage in the category adaptations for
housing. In addition, positive outcome expectations were
negatively associated with usage within the category
adaptations for housing.
The total variance explained by the factors entered in the
models was 12% for mobility, 24% for household, 34% for
adaptations for housing, 38% for personal care and 47% for
orthopaedic footwear.
Discussion
This cross-sectional study demonstrates that nearly 90% of
the patients with RA possessed one or more of a selection
Table 1 Characteristics of 240 patients with rheumatoid arthritis
participating in a study on the possession and usage of assistive
devices. Results presented as median (IQR), unless specified otherwise
Total (N=240)
Sociodemographics
Age (years) 63 (18)
Female, n (%) 185 (77)
Living alone, n (%) 53 (22)




Disease duration (years) 9 (12.5)
Medication, n (%) Oral corticosteroids 42 (18)
DMARDs 215 (90)
Comorbidity, n (%) 124 (52)
Disease activity (DAS28) 4.1 (1.7)
Disease activity (VAS; 0–100 mm) 33 (36)
Pain (VAS; 0–10 cm) 3.3 (3.3)
Fatigue (VAS; 0–10 cm) 5.0 (5)
Physical and mental functioning
RAND-36 physical component (0–100) 48.7 (41.9)
RAND-36 mental component (0–100) 74.6 (28.7)
Coping strategies (CORS)
Decreasing activity (8–31) 19 (6)
Pacing (10–40) 28 (8)
Creative solution seeking (8–32) 22 (6)
Accepting (6–24) 14 (6)
Taking others into account (7–28) 20 (4)
DMARD Disease-modifying anti-rheumatic drugs, VAS visual ana-
logue scale, CORS coping with rheumatic stressors
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of 21 assistive devices. Usage rates varied among the
various categories of assistive devices, with on average
usage rates being daily in the categories orthopaedic
footwear and adaptations for housing and weekly in the
categories personal care, mobility or household. The
proportions of patients who had completely abandoned an
assistive device ranged between 8% and 23%.
The total possession rates for assistive devices in our study
were however slightly higher than the maximum rates
reported in previous studies. In previous studies, proportions
of patients possessing one or more assistive devices varied
between 34% and 78% [3, 5–7]. This difference could
probably be explained by variation in the number of assistive
devices or groups of assistive devices that were taken into
account [3, 5–7] or by differences among patient populations
(age and disease duration [3, 6]). Moreover, it has been
demonstrated before that possession of assistive devices may
vary along with country-related health care systems [5].
Similar to the results of the present study, house
adaptations and mobility devices were found to be the most
prevalent assistive devices in two previous studies [5, 6].
Usage rates as reported in the present study are hard to
compare with those of other studies concerning assistive
devices in general [2, 3, 7, 12], mainly because different
definitions of usage have been used. None of the previous
studies assessed the absolute frequency of usage as
employed in the present study. Apart from different
methods to measure usage, different assistive devices or
groups of assistive devices, patient populations and dura-
tion of follow-up have been used.
The present study is unique in the fact that the main
reasons for using or not using devices were assessed. The
most important reason to use a device was to enable or
facilitate an activity which otherwise would be impossible
or difficult, whereas not having problems with the activity
related to the device appeared to be the main reason for not
using the devices. This result underlines the importance of
assistive devices as a compensation for activity limitations.
Our findings confirm the results of previous research,
where functional limitations and disease severity were
found to predict usage [2, 7, 12]. The relationship between
specific limitations or problems and the usage of adaptive
Table 2 Frequency of possession and usage of assistive devices in patients with rheumatoid arthritis (N=240)
Possession Usage












Orthopaedic shoes 91 (38) 132 (55) 6.0 (7.5) 1.0 (1.0) 72 (80) 6 (7) 12 (13)
Orthopaedic insoles 53 (22) 5.0 (7.0) 1.0 (2.0) 43 (81) 4 (8) 6 (11)
09 Personal care Wash and dry bidet 13 (5) 3.5 (3.6) 2.0 (1.0) 11 (85) 1 (8) 1 (8)
Shower chair 69 (29) 82 (34) 4.0 (7.5)d 4.0 (3.0) 31 (46) 19 (28) 18 (27)
Sock aid 3 (1) 9.5 (1.0)d 7.0 (7.0)d 1 (33) 0 2 (67)
Bathtub seat–elevator 11 (5) 5.0 (8.0) 7.0 (4.0) 2 (18) 3 (27) 6 (55)
12 Mobility Work chair 27 (11) 10.0 (8.0) 2.0 (1.0) 21 (78) 3 (11) 3 (11)
Rolling walker 37 (15) 2.0 (3.0) 4.0 (6.0) 17 (47) 8 (22) 11 (31)
Mobility scooter 21 (9) 85 (35) 4.5 (6.6) 4.0 (1.0) 9 (47) 6 (32) 4 (21)
Electric wheelchair 1 (0) 10.0 (0)c 2.0 (0)c 1 (100) 0 0
Wheelchair 29 (12) 4.5 (7.9) 6.5 (3.0) 1 (4) 6 (32) 21 (75)
Bicycle with electric support 15 (6) 3.0 (3.0) 4.0 (4.0) 7 (47) 3 (20) 5 (33)
15 Household Loop scissors 17 (7) 10.0 (6.5) 5.0 (3.0) 3 (18) 9 (53) 5 (29)
Reacher 27 (11) 104 (43) 5.0 (6.5) 3.0 (4.0) 23 (64) 4 (11) 9 (25)
Good–angled grip cutlery 36 (15) 6.0 (7.5) 5.0 (3.0) 6 (22) 11 (41) 10 (37)
Electric can opener 65 (27) 10.0 (14.3) 6.0 (2.0) 4 (6) 24 (37) 37 (57)
18 Adaptations for
housing
Lift chair 36 (15) 3.5 (5.5) 2.0 (0.0) 31 (91) 0 3 (9)
Stairway chair lift 15 (6) 4.0 (8.8) 2.0 (0.0) 12 (86) 0 2 (14)
Grab bars 105 (44) 170 (71) 5.0 (8.0) 3.0 (6.0) 66 (64) 8 (8) 30 (29)
Electric bedspring 56 (23) 4.5 (8.0) 4.0 (4.0) 25 (46) 10 (18) 20 (36)
Orthopaedic pillow 76 (32) 5.0 (7.0) 1.0 (2.0) 60 (79) 4 (5) 12 (16)
a Number (%) possessing one or more assistive devices within category
b Duration of possession in years
c Frequencies usage: 1 ‘always’; 2 ‘several times a day’; 3 ‘once a day’; 4 ‘several times a week’; 5 ‘once a week’; 6 ‘once a month’; 7 ‘less
than once a month’; 8 ‘never’; Daily = always + several times a day + once a day; Weekly = several times a week + once a week; Monthly or
never = once a month + less than once a month + never
d Range instead of IQR
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devices could imply that the prescription of assistive
devices should preferably be confined to those patients that
currently have or are likely in the future to have an
impairment or activity limitation related to the device. The
previously observed relationships between usage and the
sociodemographic variables age and gender are contradic-
tory [2, 7, 11]. In this study, neither an association of usage
with age nor with gender could be confirmed.
With respect to satisfaction with the device and the
providing process, it was found that the majority of the
patients were satisfied or very satisfied with the devices as
well as with the providing process, so there appears to be





Shower chair Electr. can
opener
Grab bars Electr. bedspring Orthopaedic
pillow
Satisfaction device
Dimensions 50/75 (67) 40/44 (91) 53/58 (91) 50/57 (88) 82/87 (94) 42/43 (98) 53/65 (82)
Weight 51/75 (68) 42/43 (98) 48/50 (96) 48/57 (84) 52/54 (96) 26/30 (87) 57/64 (89)
Adjustments 44/53 (83) 18/22 (82) 46/49 (94) 24/40 (60) 44/49 (90) 39/42 (93) 20/26 (77)
Safety 58/66 (82) 28/30 (93) 49/55 (89) 49/56 (88) 81/84 (96) 41/41 (100) 39/40 (98)
Durability 65/76 (86) 33/43 (77) 54/57 (95) 50/55 (91) 82/84 (98) 40/42 (95) 56/62 (90)
Ease of use 58/74 (78) 39/43 (91) 51/58 (95) 46/57 (81) 81/86 (94) 42/43 (98) 57/65 (88)
Comfort 54/76 (71) 39/43 (91) 48/58 (83) 49/57 (86) 79/85 (93) 42/43 (98) 53/66 (80)
Effectiveness 61/75 (81) 38/44 (86) 50/57 (88) 48/56 (86) 82/87 (94) 43/43 (100) 56/65 (86)
General score assistive device 58/77 (75) 38/44 (86) 50/59 (85) 48/57 (84) 84/89 (94) 41/44 (93) 56/66 (85)
Satisfaction providing process
Service delivery 61/75 (81) 39/43 (91) 45/52 (87) 16/19 (84) 59/65 (91) 17/21 (81) 25/31 (81)
Repairs and servicing 52/61 (85) 24/30 (80) 29/32 (91) 16/17 (94) 31/34 (91) 15/18 (83) 16/18 (89)
Professional services 60/75 (80) 37/43 (86) 44/49 (90) 15/18 (83) 50/61 (82) 18/20 (90) 27/30 (90)
Follow-up services 63/70 (90) 28/35 (80) 37/41 (90) 10/11 (91) 48/54 (89) 17/19 (90) 16/19 (84)
General score providing process 62/74 (84) 37/43 (86) 46/50 (92) 14/17 (82) 57/65 (88) 21/23 (91) 29/34 (85)
Results are presented as number (satisfied–very satisfied) / number responders (%)











Pain (VAS; 0–100 mm) 1.7 (1.2–2.5)
Impairment or activity limitation related
to a specific assistive device
2.6 (1.2–5.5) 2.8 (1.3–5.9)
Coping: accepting 1.1 (1.02–1.3)
Outcome expectations 0.4 (0.2–0.8)
Self-efficacy 2.5 (1.2–5.1) 2.4 (1.2–4.7)
Satisfaction assistive device (D-Quest) 20.3 (4.6- 90.1) 5.0 (1.0–26.2)
Satisfaction providing process (D-Quest) 9.1 (2.4–34.5)
Duration of possession (years) 0.9 (0.9–0.99)
Number of devices in possession
in the category
0.1 (0.02–0.64) 2.7 (1.2–6.2)
R2 0.47 0.38 0.12 0.24 0.34
Independent variables that were significantly associated with usage in the univariate analyses (p≤0.05) were entered into a multivariate logistic
regression model: ISO6: DAS28, impairment or activity limitation related to device, RAND-36 physical, coping: taking others into account,
satisfaction assistive device, satisfaction providing process, number of devices in possession. ISO9: level of education, pain (VAS), fatigue (VAS),
disease activity (VAS), impairment or activity limitation related to device, RAND-36 physical and mental, satisfaction assistive device. ISO12:
self-efficacy. ISO15: impairment or activity limitation related to device, self-efficacy, duration of possession, number of devices in possession.
ISO18: pain (VAS), fatigue (VAS), impairment or activity limitation related to device, RAND-36 physical and mental, coping: decreasing activity,
creative solution seeking and accepting, outcome expectations, satisfaction assistive device, satisfaction providing process. Freq. use (>median
usage rate) vs. non-freq. use (≤median usage rate)
VAS Visual analogue scale, D-Quest Dutch version of the Quebec User Evaluation of Satisfaction with assistive Technology, R2 Nagelkerke R2 =
pseudo measure for proportion explained variance
a Adjusted odds ratios with 95% confidence intervals, logistic regression with centre, age and gender entered first and significant independent
variables entered second
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little room for improvement. The somewhat lower satisfac-
tion rates for orthopaedic footwear could mean that a
thorough evaluation of the design of orthopaedic shoes is
desirable. According to the comments made by the patients,
the weight, comfort and the fitting of the orthopaedic shoes
could be improved. The results of our study stress the need
for the further development of orthopaedic footwear design,
including functional aspects, comfort and aesthetics.
The results of this study show that positive outcome
expectations appeared to be associated with less-frequent
usage in the category adaptations for housing. A significant
association between outcome expectations and usage was
absent in all other categories. Regarding the interpretation
of the relationship between outcome expectations and
usage, it should be noted that this study had a cross-
sectional design, and the recall of outcome expectations
may have been biased by positive or negative experiences
with the device. To explore the relation between the out-
come expectations and usage, a prospective design would
have been more preferable.
In our study, reasons for usage and non-usage were listed
by means of in-depth interviews, with the patients’
responses being categorised afterwards. This approach
was chosen in the absence of a list of topics or ques-
tionnaires specifically addressing assistive device utilisa-
tion. After this study had been conducted, there have been
advances in the field of assistive technology outcomes
research, such as the development of a model for assistive
technology usage [20]. According to this model, the
intention to use assistive devices is a function of perceived
advantages in terms of effectiveness, efficiency, satisfaction
and subjective well-being and might be modified by
personal characteristics, task, strength of the assistive
device intervention (including characteristics of the device
and associated services) and environmental factors [20, 21].
Until now, this model has not been validated. It appears,
however, that the factors that were found to be significantly
associated with the usage of assistive devices in the present
study would fit well into this model.
The present study has a number of other limitations.
First, despite the fact that the response rate was satisfactory
and three centres were included, it cannot be excluded that
patients who participated were different from the general
population of RA patients. For the comparisons between
participants and non-participants, it was indeed found that
the proportion of female patients was higher among the
participants. It could be hypothesised that patients with
assistive devices in possession could have been more willing
to participate or that patients who are old or have serious
disabilities or working patients might be less likely to
participate in a trial where the completion of extensive
questionnaire and an outpatient visit is required. Moreover,
with the interview, we used a photo presentation of only one
type of the specific assistive device. It can therefore not be
totally ruled out that patients did not recognise it in case they
possessed another type. In addition, patients were not
explicitly asked to take their devices with them to the
interview, so that neither the possession nor the adequate
usage of the device could be systematically verified. The
cross-sectional design of this study also precludes definite
conclusions on the exact moment of abandonment of the
assistive devices. For those specific research questions, a
prospective design is preferable. Moreover, although all
analyses were adjusted for each centre, it cannot be totally
ruled out that there have been general differences in the
process of advice, prescription, delivery and evaluation
among the three centres or even among rheumatologists or
other health professionals within one centre. In this study, no
detailed information on the prescription process, including,
e.g. group education sessions or training procedures, was
gathered. The reason for this lies in the fact that most patients
would have more than one assistive device and would have
to give details on the prescription process by recall, while the
average duration of possession was considerable. For a
profound analysis of the impact of the prescription process
on the usage of assistive devices, an additional, prospective
study taking into account all the details of the prescription
process would be needed.
In conclusion, nearly 90% of the patients with RA
possessed one or more of a selection of 21 assistive devices.
Less than 23% of these devices in possession were
abandoned and satisfaction with the devices and providing
process was high. Factors associated with usage varied
among categories and comprised, apart from the number of
devices, variables related to health status, aspects of satis-
faction with the device or related services or self-efficacy.
The latter finding underlines the need for a structural eval-
uation of the outcomes of assistive devices by the prescribing
health professional or supplier in every individual case.
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